Literature DB >> 9771471

Regulation of Leydig cells through a steroidogenic acute regulatory protein-independent pathway by a lipophilic factor from macrophages.

Y O Lukyanenko1, A M Carpenter, D E Brigham, D M Stocco, J C Hutson.   

Abstract

The purpose of this investigation was to study the mechanism of action of a macrophage-derived factor that stimulates steroid production by Leydig cells. This factor increased testosterone production within 30 min, and reached a half-maximal response by 6-8 h. At a maximal dose, it stimulated testosterone production 20-fold at 24 h. Its efficacy was consistently higher than that achieved with a maximal dose of human chorionic gonadotropin (hCG). However, Leydig cells treated with a maximal dose of both the macrophage-derived factor and hCG secreted the same amount of testosterone as when given a maximal dose of only the macrophage-derived factor. The macrophage-derived factor did not require new protein synthesis to stimulate testosterone production, nor did it alter the amount of steroidogenic acute regulatory protein (StAR). While the macrophage-derived factor required an active cholesterol side-chain cleavage complex system, it did not alter the capacity of this enzyme complex. Finally, the macrophage-derived factor was unable to stimulate the production of progesterone by isolated mitochondria. In summary, the macrophage-derived factor is a highly active, acute regulator of steroidogenesis that acts through a high capacity StAR-independent pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771471     DOI: 10.1677/joe.0.1580267

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

2.  The Effect of Cordycepin on Steroidogenesis and Apoptosis in MA-10 Mouse Leydig Tumor Cells.

Authors:  Bo-Syong Pan; Chun-Yu Lin; Bu-Miin Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

3.  Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?

Authors:  Hanan Goldberg; Liat Shavit Grievink; Roy Mano; Yaara Ber; Rachely Ozalbo; Sivan Tuval; Jack Baniel; David Margel
Journal:  Oncotarget       Date:  2017-10-10

Review 4.  Cell-specific ablation in the testis: what have we learned?

Authors:  L B Smith; P J O'Shaughnessy; D Rebourcet
Journal:  Andrology       Date:  2015-10-07       Impact factor: 3.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.